Information Provided By: 
Fly News Breaks for December 6, 2018
EW
Dec 6, 2018 | 09:25 EDT
Stifel analyst Rick Wise called Edwards Lifesciences' analyst day "broadly positive," stating that it highlighted the company's "expansive pipeline" of products that can potentially enhance growth. The company's longer-term market sizing discussion suggests management sees sustainable mid-teens TAVR market growth through the middle of next decade, noted Wise. Following the event, he keeps a Buy rating on Edwards and increased his price target on the stock to $175 from $155.
News For EW From the Last 2 Days
There are no results for your query EW
